nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2C8—Mometasone—systemic scleroderma	0.12	0.18	CbGbCtD
Azelastine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0629	0.0941	CbGbCtD
Azelastine—CYP1A2—Leflunomide—systemic scleroderma	0.06	0.0898	CbGbCtD
Azelastine—ABCB1—Lisinopril—systemic scleroderma	0.055	0.0823	CbGbCtD
Azelastine—CYP2C9—Leflunomide—systemic scleroderma	0.054	0.0809	CbGbCtD
Azelastine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0498	0.0745	CbGbCtD
Azelastine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0479	0.0717	CbGbCtD
Azelastine—ABCB1—Captopril—systemic scleroderma	0.0411	0.0616	CbGbCtD
Azelastine—CYP2D6—Captopril—systemic scleroderma	0.0388	0.0581	CbGbCtD
Azelastine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0324	0.0485	CbGbCtD
Azelastine—CYP2C19—Prednisone—systemic scleroderma	0.0321	0.0481	CbGbCtD
Azelastine—ABCB1—Prednisone—systemic scleroderma	0.0259	0.0388	CbGbCtD
Azelastine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0194	0.0291	CbGbCtD
Azelastine—CYP3A4—Prednisone—systemic scleroderma	0.0155	0.0232	CbGbCtD
Azelastine—ABCB1—Methotrexate—systemic scleroderma	0.013	0.0195	CbGbCtD
Azelastine—CYP2C9—cardial valve—systemic scleroderma	0.00496	0.433	CbGeAlD
Azelastine—HRH3—digestive system—systemic scleroderma	0.000913	0.0798	CbGeAlD
Azelastine—Nervousness—Lisinopril—systemic scleroderma	0.000421	0.00131	CcSEcCtD
Azelastine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00131	CcSEcCtD
Azelastine—Dry mouth—Leflunomide—systemic scleroderma	0.00042	0.00131	CcSEcCtD
Azelastine—Cough—Mycophenolic acid—systemic scleroderma	0.00042	0.00131	CcSEcCtD
Azelastine—Back pain—Lisinopril—systemic scleroderma	0.000419	0.00131	CcSEcCtD
Azelastine—Vomiting—Pentoxifylline—systemic scleroderma	0.000419	0.00131	CcSEcCtD
Azelastine—Rash—Pentoxifylline—systemic scleroderma	0.000416	0.0013	CcSEcCtD
Azelastine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000415	0.0013	CcSEcCtD
Azelastine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000415	0.00129	CcSEcCtD
Azelastine—Headache—Pentoxifylline—systemic scleroderma	0.000413	0.00129	CcSEcCtD
Azelastine—Face oedema—Prednisone—systemic scleroderma	0.000413	0.00129	CcSEcCtD
Azelastine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000412	0.00128	CcSEcCtD
Azelastine—Feeling abnormal—Captopril—systemic scleroderma	0.000412	0.00128	CcSEcCtD
Azelastine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00041	0.00128	CcSEcCtD
Azelastine—Myalgia—Mycophenolic acid—systemic scleroderma	0.00041	0.00128	CcSEcCtD
Azelastine—Infection—Leflunomide—systemic scleroderma	0.000409	0.00128	CcSEcCtD
Azelastine—Vision blurred—Lisinopril—systemic scleroderma	0.000409	0.00127	CcSEcCtD
Azelastine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000408	0.00127	CcSEcCtD
Azelastine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000408	0.00127	CcSEcCtD
Azelastine—Asthenia—Mometasone—systemic scleroderma	0.000408	0.00127	CcSEcCtD
Azelastine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00127	CcSEcCtD
Azelastine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000405	0.00126	CcSEcCtD
Azelastine—Pruritus—Mometasone—systemic scleroderma	0.000402	0.00125	CcSEcCtD
Azelastine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000402	0.00125	CcSEcCtD
Azelastine—Tachycardia—Leflunomide—systemic scleroderma	0.000402	0.00125	CcSEcCtD
Azelastine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000401	0.00125	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000397	0.00124	CcSEcCtD
Azelastine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000396	0.00123	CcSEcCtD
Azelastine—Abdominal pain—Captopril—systemic scleroderma	0.000395	0.00123	CcSEcCtD
Azelastine—Body temperature increased—Captopril—systemic scleroderma	0.000395	0.00123	CcSEcCtD
Azelastine—Nausea—Pentoxifylline—systemic scleroderma	0.000392	0.00122	CcSEcCtD
Azelastine—Malaise—Lisinopril—systemic scleroderma	0.000391	0.00122	CcSEcCtD
Azelastine—Infection—Mycophenolic acid—systemic scleroderma	0.00039	0.00122	CcSEcCtD
Azelastine—Vertigo—Lisinopril—systemic scleroderma	0.000389	0.00121	CcSEcCtD
Azelastine—Diarrhoea—Mometasone—systemic scleroderma	0.000389	0.00121	CcSEcCtD
Azelastine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000383	0.0012	CcSEcCtD
Azelastine—Palpitations—Lisinopril—systemic scleroderma	0.000383	0.00119	CcSEcCtD
Azelastine—Cough—Lisinopril—systemic scleroderma	0.000378	0.00118	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000377	0.00118	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000375	0.00117	CcSEcCtD
Azelastine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00116	CcSEcCtD
Azelastine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00116	CcSEcCtD
Azelastine—Paraesthesia—Leflunomide—systemic scleroderma	0.00037	0.00115	CcSEcCtD
Azelastine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000369	0.00115	CcSEcCtD
Azelastine—Chest pain—Lisinopril—systemic scleroderma	0.000369	0.00115	CcSEcCtD
Azelastine—Myalgia—Lisinopril—systemic scleroderma	0.000369	0.00115	CcSEcCtD
Azelastine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000369	0.00115	CcSEcCtD
Azelastine—Anxiety—Lisinopril—systemic scleroderma	0.000368	0.00115	CcSEcCtD
Azelastine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00115	CcSEcCtD
Azelastine—Dyspnoea—Leflunomide—systemic scleroderma	0.000367	0.00114	CcSEcCtD
Azelastine—Discomfort—Lisinopril—systemic scleroderma	0.000365	0.00114	CcSEcCtD
Azelastine—Vomiting—Mometasone—systemic scleroderma	0.000362	0.00113	CcSEcCtD
Azelastine—Dry mouth—Lisinopril—systemic scleroderma	0.000361	0.00113	CcSEcCtD
Azelastine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000359	0.00112	CcSEcCtD
Azelastine—CYP2A6—lung—systemic scleroderma	0.000359	0.0314	CbGeAlD
Azelastine—Rash—Mometasone—systemic scleroderma	0.000359	0.00112	CcSEcCtD
Azelastine—Asthenia—Captopril—systemic scleroderma	0.000358	0.00112	CcSEcCtD
Azelastine—Dermatitis—Mometasone—systemic scleroderma	0.000358	0.00112	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000358	0.00112	CcSEcCtD
Azelastine—Confusional state—Lisinopril—systemic scleroderma	0.000357	0.00111	CcSEcCtD
Azelastine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000357	0.00111	CcSEcCtD
Azelastine—Headache—Mometasone—systemic scleroderma	0.000356	0.00111	CcSEcCtD
Azelastine—Fatigue—Leflunomide—systemic scleroderma	0.000355	0.00111	CcSEcCtD
Azelastine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000354	0.0011	CcSEcCtD
Azelastine—Pruritus—Captopril—systemic scleroderma	0.000353	0.0011	CcSEcCtD
Azelastine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000353	0.0011	CcSEcCtD
Azelastine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000352	0.0011	CcSEcCtD
Azelastine—Constipation—Leflunomide—systemic scleroderma	0.000352	0.0011	CcSEcCtD
Azelastine—Pain—Leflunomide—systemic scleroderma	0.000352	0.0011	CcSEcCtD
Azelastine—Infection—Lisinopril—systemic scleroderma	0.000351	0.0011	CcSEcCtD
Azelastine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00035	0.00109	CcSEcCtD
Azelastine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000349	0.00109	CcSEcCtD
Azelastine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00109	CcSEcCtD
Azelastine—Tachycardia—Lisinopril—systemic scleroderma	0.000345	0.00108	CcSEcCtD
Azelastine—Abdominal pain—Azathioprine—systemic scleroderma	0.000345	0.00107	CcSEcCtD
Azelastine—Body temperature increased—Azathioprine—systemic scleroderma	0.000345	0.00107	CcSEcCtD
Azelastine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00107	CcSEcCtD
Azelastine—Diarrhoea—Captopril—systemic scleroderma	0.000342	0.00107	CcSEcCtD
Azelastine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00106	CcSEcCtD
Azelastine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000339	0.00106	CcSEcCtD
Azelastine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000339	0.00106	CcSEcCtD
Azelastine—Nausea—Mometasone—systemic scleroderma	0.000338	0.00105	CcSEcCtD
Azelastine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000337	0.00105	CcSEcCtD
Azelastine—Weight increased—Prednisone—systemic scleroderma	0.000336	0.00105	CcSEcCtD
Azelastine—Pain—Mycophenolic acid—systemic scleroderma	0.000336	0.00105	CcSEcCtD
Azelastine—Constipation—Mycophenolic acid—systemic scleroderma	0.000336	0.00105	CcSEcCtD
Azelastine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00105	CcSEcCtD
Azelastine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000331	0.00103	CcSEcCtD
Azelastine—Dizziness—Captopril—systemic scleroderma	0.00033	0.00103	CcSEcCtD
Azelastine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00102	CcSEcCtD
Azelastine—Abdominal pain—Leflunomide—systemic scleroderma	0.000325	0.00101	CcSEcCtD
Azelastine—Body temperature increased—Leflunomide—systemic scleroderma	0.000325	0.00101	CcSEcCtD
Azelastine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000324	0.00101	CcSEcCtD
Azelastine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00101	CcSEcCtD
Azelastine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00101	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000322	0.001	CcSEcCtD
Azelastine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000322	0.001	CcSEcCtD
Azelastine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000321	0.001	CcSEcCtD
Azelastine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000321	0.001	CcSEcCtD
Azelastine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000996	CcSEcCtD
Azelastine—Paraesthesia—Lisinopril—systemic scleroderma	0.000318	0.00099	CcSEcCtD
Azelastine—Vomiting—Captopril—systemic scleroderma	0.000318	0.00099	CcSEcCtD
Azelastine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000986	CcSEcCtD
Azelastine—Dyspnoea—Lisinopril—systemic scleroderma	0.000315	0.000983	CcSEcCtD
Azelastine—Rash—Captopril—systemic scleroderma	0.000315	0.000982	CcSEcCtD
Azelastine—Dermatitis—Captopril—systemic scleroderma	0.000315	0.000981	CcSEcCtD
Azelastine—Somnolence—Lisinopril—systemic scleroderma	0.000315	0.00098	CcSEcCtD
Azelastine—Headache—Captopril—systemic scleroderma	0.000313	0.000976	CcSEcCtD
Azelastine—ABCB1—blood vessel—systemic scleroderma	0.000313	0.0273	CbGeAlD
Azelastine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000974	CcSEcCtD
Azelastine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00031	0.000968	CcSEcCtD
Azelastine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00031	0.000968	CcSEcCtD
Azelastine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00031	0.000966	CcSEcCtD
Azelastine—Asthma—Methotrexate—systemic scleroderma	0.000309	0.000963	CcSEcCtD
Azelastine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00096	CcSEcCtD
Azelastine—Fatigue—Lisinopril—systemic scleroderma	0.000305	0.000951	CcSEcCtD
Azelastine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000303	0.000946	CcSEcCtD
Azelastine—Constipation—Lisinopril—systemic scleroderma	0.000303	0.000943	CcSEcCtD
Azelastine—Pain—Lisinopril—systemic scleroderma	0.000303	0.000943	CcSEcCtD
Azelastine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000943	CcSEcCtD
Azelastine—Diarrhoea—Azathioprine—systemic scleroderma	0.000298	0.00093	CcSEcCtD
Azelastine—Nausea—Captopril—systemic scleroderma	0.000297	0.000925	CcSEcCtD
Azelastine—Asthenia—Leflunomide—systemic scleroderma	0.000295	0.000921	CcSEcCtD
Azelastine—HRH1—connective tissue—systemic scleroderma	0.000293	0.0256	CbGeAlD
Azelastine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000292	0.000909	CcSEcCtD
Azelastine—Pruritus—Leflunomide—systemic scleroderma	0.000291	0.000908	CcSEcCtD
Azelastine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000289	0.000902	CcSEcCtD
Azelastine—Dizziness—Azathioprine—systemic scleroderma	0.000288	0.000899	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000287	0.000895	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00088	CcSEcCtD
Azelastine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000282	0.000879	CcSEcCtD
Azelastine—Diarrhoea—Leflunomide—systemic scleroderma	0.000282	0.000878	CcSEcCtD
Azelastine—Body temperature increased—Lisinopril—systemic scleroderma	0.00028	0.000872	CcSEcCtD
Azelastine—Abdominal pain—Lisinopril—systemic scleroderma	0.00028	0.000872	CcSEcCtD
Azelastine—CYP1A1—skin of body—systemic scleroderma	0.000279	0.0243	CbGeAlD
Azelastine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000868	CcSEcCtD
Azelastine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000278	0.000866	CcSEcCtD
Azelastine—Vomiting—Azathioprine—systemic scleroderma	0.000277	0.000864	CcSEcCtD
Azelastine—CYP2C19—digestive system—systemic scleroderma	0.000277	0.0242	CbGeAlD
Azelastine—Eye disorder—Prednisone—systemic scleroderma	0.000276	0.000862	CcSEcCtD
Azelastine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000862	CcSEcCtD
Azelastine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000859	CcSEcCtD
Azelastine—Rash—Azathioprine—systemic scleroderma	0.000275	0.000857	CcSEcCtD
Azelastine—Dermatitis—Azathioprine—systemic scleroderma	0.000275	0.000856	CcSEcCtD
Azelastine—Flushing—Prednisone—systemic scleroderma	0.000274	0.000856	CcSEcCtD
Azelastine—Headache—Azathioprine—systemic scleroderma	0.000273	0.000851	CcSEcCtD
Azelastine—Dizziness—Leflunomide—systemic scleroderma	0.000272	0.000849	CcSEcCtD
Azelastine—CYP2B6—skin of body—systemic scleroderma	0.000271	0.0236	CbGeAlD
Azelastine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000269	0.000838	CcSEcCtD
Azelastine—HRH1—smooth muscle tissue—systemic scleroderma	0.000268	0.0234	CbGeAlD
Azelastine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000268	0.000834	CcSEcCtD
Azelastine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000826	CcSEcCtD
Azelastine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000826	CcSEcCtD
Azelastine—Haematuria—Methotrexate—systemic scleroderma	0.000263	0.000818	CcSEcCtD
Azelastine—Vomiting—Leflunomide—systemic scleroderma	0.000262	0.000816	CcSEcCtD
Azelastine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000261	0.000813	CcSEcCtD
Azelastine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00026	0.00081	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—systemic scleroderma	0.00026	0.00081	CcSEcCtD
Azelastine—Rash—Leflunomide—systemic scleroderma	0.00026	0.000809	CcSEcCtD
Azelastine—Dermatitis—Leflunomide—systemic scleroderma	0.000259	0.000809	CcSEcCtD
Azelastine—Nausea—Azathioprine—systemic scleroderma	0.000259	0.000807	CcSEcCtD
Azelastine—Headache—Leflunomide—systemic scleroderma	0.000258	0.000804	CcSEcCtD
Azelastine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000796	CcSEcCtD
Azelastine—Asthenia—Lisinopril—systemic scleroderma	0.000254	0.000791	CcSEcCtD
Azelastine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00079	CcSEcCtD
Azelastine—Pruritus—Lisinopril—systemic scleroderma	0.00025	0.00078	CcSEcCtD
Azelastine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00025	0.000779	CcSEcCtD
Azelastine—Rash—Mycophenolic acid—systemic scleroderma	0.000248	0.000772	CcSEcCtD
Azelastine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000247	0.000771	CcSEcCtD
Azelastine—Headache—Mycophenolic acid—systemic scleroderma	0.000246	0.000767	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—systemic scleroderma	0.000245	0.000765	CcSEcCtD
Azelastine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000764	CcSEcCtD
Azelastine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000764	CcSEcCtD
Azelastine—Nausea—Leflunomide—systemic scleroderma	0.000245	0.000762	CcSEcCtD
Azelastine—Vision blurred—Prednisone—systemic scleroderma	0.000243	0.000756	CcSEcCtD
Azelastine—Diarrhoea—Lisinopril—systemic scleroderma	0.000242	0.000755	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000239	0.000745	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—systemic scleroderma	0.000238	0.000743	CcSEcCtD
Azelastine—Agitation—Prednisone—systemic scleroderma	0.000237	0.000738	CcSEcCtD
Azelastine—Dizziness—Lisinopril—systemic scleroderma	0.000234	0.000729	CcSEcCtD
Azelastine—Nausea—Mycophenolic acid—systemic scleroderma	0.000233	0.000727	CcSEcCtD
Azelastine—Malaise—Prednisone—systemic scleroderma	0.000232	0.000724	CcSEcCtD
Azelastine—Vertigo—Prednisone—systemic scleroderma	0.000231	0.000721	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—systemic scleroderma	0.000231	0.00072	CcSEcCtD
Azelastine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000712	CcSEcCtD
Azelastine—CYP1A2—digestive system—systemic scleroderma	0.000226	0.0197	CbGeAlD
Azelastine—Vomiting—Lisinopril—systemic scleroderma	0.000225	0.000701	CcSEcCtD
Azelastine—Rash—Lisinopril—systemic scleroderma	0.000223	0.000695	CcSEcCtD
Azelastine—CYP1A1—digestive system—systemic scleroderma	0.000223	0.0195	CbGeAlD
Azelastine—Dermatitis—Lisinopril—systemic scleroderma	0.000223	0.000695	CcSEcCtD
Azelastine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000693	CcSEcCtD
Azelastine—Hypertension—Prednisone—systemic scleroderma	0.000222	0.000693	CcSEcCtD
Azelastine—Headache—Lisinopril—systemic scleroderma	0.000222	0.000691	CcSEcCtD
Azelastine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000684	CcSEcCtD
Azelastine—Myalgia—Prednisone—systemic scleroderma	0.000219	0.000683	CcSEcCtD
Azelastine—Anxiety—Prednisone—systemic scleroderma	0.000218	0.000681	CcSEcCtD
Azelastine—CYP3A5—digestive system—systemic scleroderma	0.000218	0.019	CbGeAlD
Azelastine—CYP2B6—digestive system—systemic scleroderma	0.000217	0.0189	CbGeAlD
Azelastine—Discomfort—Prednisone—systemic scleroderma	0.000217	0.000675	CcSEcCtD
Azelastine—CYP2C9—digestive system—systemic scleroderma	0.000214	0.0187	CbGeAlD
Azelastine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000661	CcSEcCtD
Azelastine—HRH1—digestive system—systemic scleroderma	0.000212	0.0185	CbGeAlD
Azelastine—Dysgeusia—Methotrexate—systemic scleroderma	0.000211	0.000657	CcSEcCtD
Azelastine—Nausea—Lisinopril—systemic scleroderma	0.00021	0.000655	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00021	0.000655	CcSEcCtD
Azelastine—Infection—Prednisone—systemic scleroderma	0.000209	0.000651	CcSEcCtD
Azelastine—Back pain—Methotrexate—systemic scleroderma	0.000208	0.000649	CcSEcCtD
Azelastine—Tachycardia—Prednisone—systemic scleroderma	0.000205	0.000639	CcSEcCtD
Azelastine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000639	CcSEcCtD
Azelastine—CYP2E1—digestive system—systemic scleroderma	0.000203	0.0177	CbGeAlD
Azelastine—Vision blurred—Methotrexate—systemic scleroderma	0.000203	0.000632	CcSEcCtD
Azelastine—HRH1—tendon—systemic scleroderma	0.000201	0.0176	CbGeAlD
Azelastine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.0002	0.000622	CcSEcCtD
Azelastine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000614	CcSEcCtD
Azelastine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000609	CcSEcCtD
Azelastine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000609	CcSEcCtD
Azelastine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000605	CcSEcCtD
Azelastine—Malaise—Methotrexate—systemic scleroderma	0.000194	0.000605	CcSEcCtD
Azelastine—CYP2E1—tendon—systemic scleroderma	0.000193	0.0169	CbGeAlD
Azelastine—Vertigo—Methotrexate—systemic scleroderma	0.000193	0.000603	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000191	0.000597	CcSEcCtD
Azelastine—CYP1A2—lung—systemic scleroderma	0.000189	0.0165	CbGeAlD
Azelastine—Paraesthesia—Prednisone—systemic scleroderma	0.000189	0.000588	CcSEcCtD
Azelastine—Cough—Methotrexate—systemic scleroderma	0.000188	0.000585	CcSEcCtD
Azelastine—CYP1A1—lung—systemic scleroderma	0.000186	0.0163	CbGeAlD
Azelastine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000574	CcSEcCtD
Azelastine—Myalgia—Methotrexate—systemic scleroderma	0.000183	0.000571	CcSEcCtD
Azelastine—Chest pain—Methotrexate—systemic scleroderma	0.000183	0.000571	CcSEcCtD
Azelastine—CYP3A5—lung—systemic scleroderma	0.000182	0.0159	CbGeAlD
Azelastine—Fatigue—Prednisone—systemic scleroderma	0.000181	0.000565	CcSEcCtD
Azelastine—Discomfort—Methotrexate—systemic scleroderma	0.000181	0.000564	CcSEcCtD
Azelastine—CYP2B6—lung—systemic scleroderma	0.000181	0.0158	CbGeAlD
Azelastine—Constipation—Prednisone—systemic scleroderma	0.00018	0.00056	CcSEcCtD
Azelastine—Confusional state—Methotrexate—systemic scleroderma	0.000177	0.000552	CcSEcCtD
Azelastine—HRH1—lung—systemic scleroderma	0.000177	0.0154	CbGeAlD
Azelastine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000176	0.000547	CcSEcCtD
Azelastine—Infection—Methotrexate—systemic scleroderma	0.000174	0.000544	CcSEcCtD
Azelastine—Feeling abnormal—Prednisone—systemic scleroderma	0.000173	0.00054	CcSEcCtD
Azelastine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000172	0.000536	CcSEcCtD
Azelastine—CYP2E1—lung—systemic scleroderma	0.00017	0.0148	CbGeAlD
Azelastine—Abdominal pain—Prednisone—systemic scleroderma	0.000166	0.000518	CcSEcCtD
Azelastine—Body temperature increased—Prednisone—systemic scleroderma	0.000166	0.000518	CcSEcCtD
Azelastine—CYP3A4—digestive system—systemic scleroderma	0.000164	0.0143	CbGeAlD
Azelastine—CYP2D6—digestive system—systemic scleroderma	0.000161	0.0141	CbGeAlD
Azelastine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00016	0.000499	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—systemic scleroderma	0.000158	0.000492	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—systemic scleroderma	0.000157	0.000488	CcSEcCtD
Azelastine—Somnolence—Methotrexate—systemic scleroderma	0.000156	0.000487	CcSEcCtD
Azelastine—Hypersensitivity—Prednisone—systemic scleroderma	0.000155	0.000483	CcSEcCtD
Azelastine—Fatigue—Methotrexate—systemic scleroderma	0.000151	0.000472	CcSEcCtD
Azelastine—Asthenia—Prednisone—systemic scleroderma	0.000151	0.00047	CcSEcCtD
Azelastine—Pain—Methotrexate—systemic scleroderma	0.00015	0.000468	CcSEcCtD
Azelastine—Pruritus—Prednisone—systemic scleroderma	0.000149	0.000463	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000145	0.000451	CcSEcCtD
Azelastine—Diarrhoea—Prednisone—systemic scleroderma	0.000144	0.000448	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000144	0.000448	CcSEcCtD
Azelastine—Dizziness—Prednisone—systemic scleroderma	0.000139	0.000433	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—systemic scleroderma	0.000139	0.000433	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—systemic scleroderma	0.000139	0.000433	CcSEcCtD
Azelastine—Vomiting—Prednisone—systemic scleroderma	0.000134	0.000416	CcSEcCtD
Azelastine—Rash—Prednisone—systemic scleroderma	0.000132	0.000413	CcSEcCtD
Azelastine—Dermatitis—Prednisone—systemic scleroderma	0.000132	0.000413	CcSEcCtD
Azelastine—Headache—Prednisone—systemic scleroderma	0.000132	0.00041	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000129	0.000403	CcSEcCtD
Azelastine—Asthenia—Methotrexate—systemic scleroderma	0.000126	0.000393	CcSEcCtD
Azelastine—Nausea—Prednisone—systemic scleroderma	0.000125	0.000389	CcSEcCtD
Azelastine—Pruritus—Methotrexate—systemic scleroderma	0.000124	0.000387	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—systemic scleroderma	0.00012	0.000375	CcSEcCtD
Azelastine—Dizziness—Methotrexate—systemic scleroderma	0.000116	0.000362	CcSEcCtD
Azelastine—ABCB1—digestive system—systemic scleroderma	0.000116	0.0101	CbGeAlD
Azelastine—Vomiting—Methotrexate—systemic scleroderma	0.000112	0.000348	CcSEcCtD
Azelastine—Rash—Methotrexate—systemic scleroderma	0.000111	0.000345	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—systemic scleroderma	0.000111	0.000345	CcSEcCtD
Azelastine—Headache—Methotrexate—systemic scleroderma	0.00011	0.000343	CcSEcCtD
Azelastine—Nausea—Methotrexate—systemic scleroderma	0.000104	0.000325	CcSEcCtD
Azelastine—ABCB1—lung—systemic scleroderma	9.67e-05	0.00844	CbGeAlD
